Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I

Affiliations

• ¹ Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
• ² Center for Melanoma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Harvard University, Boston, MA, United States.
• ³ School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
• ⁴ School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
• ⁵ Melbourne School of Population and Global Health, The University of Melbourne, Carlton, VIC, Australia.
• ⁶ Centre of Cancer Research, Victorian Comprehensive Cancer Centre Project, Melbourne, VIC, Australia.